An Integrative Analysis of the Immune Features of Inactivated SARS-CoV-2 Vaccine (CoronaVac)

Currently, an inactivated vaccine has been widely used with encouraging results as a prophylactic agent against COVID-19 infection, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its variants. However, in vitro SARS-CoV-2 vaccine-specific immune features remain e...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Zhujun, Lin, Haishuang, Zhang, Haoran, Shi, Ningning, Zheng, Zhetao, Dong, Liangzhen, Yang, Yuelin, Xia, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231306/
https://www.ncbi.nlm.nih.gov/pubmed/35746486
http://dx.doi.org/10.3390/vaccines10060878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231306/
https://www.ncbi.nlm.nih.gov/pubmed/35746486
http://dx.doi.org/10.3390/vaccines10060878

Ejemplares similares